AbbVie is a global, research-based biopharmaceutical company
formed in 2013 following separation from Abbott Laboratories.
The company’s mission is to use its expertise, dedicated people and
unique approach to innovation to develop and market advanced
therapies that address some of the world’s most complex and serious
diseases. Together with its wholly-owned subsidiary, Pharmacyclics,
AbbVie employs more than 28,000 people worldwide and markets
medicines in more than 170 countries.
AbbVie Contract Manufacturing
AbbVie continues a legacy of more than a century at the forefront
of pharmaceutical development and manufacturing. For more
than 30 years, the company has offered contract manufacturing
services that today comprise biologics, potent, drug product,
fermentation, prefilled syringe manufacturing and hot melt
extrusion, as well as selling high-quality active pharmaceutical
The creation of AbbVie streamlined the business to solely drug
development. Combining the focus of a biotech with the expertise
of an established pharmaceutical leader, the contract manufacturing
business is agile and flexible in its service to companies outsourcing
the development and manufacture of drugs.
AbbVie Contract Manufacturing has a portfolio of 10 state-of-the-art facilities, offering a broad range of capabilities in North America
and Europe. Clients are reliably served by a company with one of
the industry’s leading reputations for high-quality, on-time delivery.
The company takes pride in its outstanding customer service record,
with experienced planning and project management specialists
dedicating specific time slots for contract manufacturing.
AbbVie Contract Manufacturing serves domestic and global
companies seeking to outsource biologics, potent, drug
product, fermentation, prefilled syringe manufacturing and hot
melt extrusion, as well as businesses looking to procure APIs.
Outsourcing clients range from mid-size to large pharmaceutical
and biotech companies.
As a leading biopharmaceutical developer and manufacturer,
AbbVie’s scientific team offers expertise in process optimization,
analytical characterization and cGMP manufacturing—supporting
full development and commercialization of biologics.
AbbVie Contract Manufacturing offers a full range of potent
capabilities for drug product and active pharmaceutical ingredients
(HPAPIs), covering development phases to commercial equipment
capable of handling potent classification of <1 μg/m3.
AbbVie Contract Manufacturing offers a full range of drug product
manufacturing from a global network of proven facilities. Clients’
needs are met from development to commercial phases, with
services supporting material procurement, process optimization,
formulation, testing and stability.
AbbVie Contract Manufacturing offers world-class small
molecule fermentation capabilities with working capacities in
excess of 3,500m3 and expertise based on more than 60 years’ in
The newest manufacturing capability added to AbbVie Contract
Manufacturing’s portfolio is prefilled syringe. We offer services
incorporating development through commercial manufacturing
at our state-of-the-art facility in Barceloneta, Puerto Rico.
Hot Melt Extrusion (HME)
Experienced in development to commercial for difficult to formulate
HME products. Extrusion capabilities from 9 mm to 70 mm.
Active Pharmaceutical Ingredients
AbbVie manufactures a wide range of compendia-grade active
pharmaceutical ingredients and a variety of packaging sizes to
meet the needs of companies seeking to procure these materials.
AbbVie Contract Manufacturing
1401 Sheridan Road
North Chicago, IL 60064-8524
Tel: +1 847-938-8524
Fax: +1 847-937-9706